Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age

Blood

Volumn 98, Issue 7, 2001, Pages 2043-2051

  Kollman, Craig ^{a,b,c,d,e,f,g,h}   Howe, Craig W S ^{a,b,c,d,e,f,g}   Anasetti, Claudio ^{a,b,c,d,e,f,g}   Antin, Joseph H ^{a,b,c,d,e,f,g}   Davies, Stella M ^{a,b,c,d,e,f,g}   Filipovich, Alexandra H ^{a,b,c,d,e,f,g}   Hegland, Janet ^{a,b,c,d,e,f,g}   Kamani, Naynesh ^{a,b,c,d,e,f,g}   Keman, Nancy A ^{a,b,c,d,e,f,g}   King, Roberta ^{a,b,c,d,e,f,g,h}   Ratanatharathorn, Voravit ^{a,b,c,d,e,f,g}   Weisdorf, Daniel ^{a,b,c,d,e,f,g}   Confer, Dennis L ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h NATIONAL MARROW DONOR PROGRAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; DISEASE SEVERITY; DONOR; EVALUATION; FEMALE; GENDER; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; INFANT; MALE; OUTCOMES RESEARCH; PREGNANCY; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE;

EID: 0035496909     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.7.2043     Document Type: Article

References (52)

1. Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med. 1980;303:1311-1318.
2. Beatty PG, Hansen JA, Longton GM, et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation. 1991;51:443-447.
3. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplants from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993;328:593-602.
4. McGlave P, Bartsch G,Anasetti C, et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood. 1993;8:543-550.
5. Armitage JO. Bone marrow transplantation. N Engl J Med. 1994;330:827-833.
6. Szydlo R, Goldman J, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997;15:1767-1777.
7. Weisdorf DJ, Billett AL, Hannan P, et al. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood. 1997;90:2962-2968.
8. Zumwalt ER Jr, Howe CWS. The origins and development of the National Marrow Donor Program. Leukemia. 1993;7:1122.
9. National Marrow Donor Program Standards Committee. Standards of the National Marrow Donor Program. Transfus Med Rev. 1993;33:172-180.
10. Perkins HA, Hansen JA. The U.S. National Marrow Donor Program. Am J Pediatr Hematol Oncol. 1994;16:30-34.
11. Petersdorf EW, Smith AG, Mickelson EM, et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood. 1993;82:667-681.
12. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, Smith AG, Hansen JA. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci U S A. 1996;93:15358-15363.
13. Petersdorf EW, Longton GM, Anasetti C, et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood. 1997;89:1818-1823.
14. Sullivan KM. Graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Stem Cell Transplantation. 2nd ed. Malden, MA: Blackwell Science; 1999:518-519.
15. Bodmer JG, Marsh SGE, Albert ED, et al. Nomenclature for factors of the HLA system, 1998. Tissue Antigens. 1999;53:407-446.
16. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji T, Aizawa M, Sasazuki T, eds. HLA 1991. Oxford, United Kingdom: Oxford University Press; 1992:397-419.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
18. Mantel M. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemther Rep. 1966;50:163-170.
19. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706.
20. Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc. 1993;88:400-409.
21. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187-220.
22. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555-562.
23. Marmont AM, Horowitz MM, Gale RP, et al. T-cell depletion of HLA-identical transplants in leukemia. Blood. 1991;78:2120-2130.
24. Horowitz MM, Przepiorka D, Champlin RE, et al. Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood. 1992;79:2771-2774.
25. Bortin MM, Horowitz MM, Rowlings PA, et al. 1993 progress report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 1993;12:97-104.
26. Passweg JR, Socie G, Hinterberger W, et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood. 1997;90: 858-864.
27. Ash RC, Horowitz MM, Gale RP, et al. Bone-marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant. 1991;7:443-452.
28. Broers AEC, van der Hold R, van Esser JWJ, et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood. 2000;95:2240-2245.
29. Miller W, Flynn P, McCullough J, et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood. 1986;67:1162-1167.
30. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med. 1998;338:962-968.
31. Weisdorf D, Hakke R, Blazar B, et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation. 1991;51:1197-1203.
32. Nash RA, Pepe MS, Storb R, et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood. 1992;80:1838-1845.
33. Carlens S, Ringdén O, Remberger M, et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant. 1998;22:755-761.
34. Przepiorka D, Smith TL, Folloder J, et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 1999;94:1465-1470.
35. Beatty P, Mori M, Milford E. Impact of racial genetic polymorphism upon the probability of finding an HLA-matched donor. Transplantation. 1995; 60:778-783.
36. McKenzie KJ, Crowcroft NS. Race, ethnicity, culture, and science. BMJ. 1994;309:286-287.
37. Witzig R. The medicalization of race: scientific legitimization of a flawed social construct. Ann Intern Med. 1996;125:675-679.
38. Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion. 1999;39:179-187.
39. Bensinger WI, Buckner CD, Thomas ED, Clift RA. ABO-incompatible marrow transplants. Transplantation. 1982;33:427-429.
40. Mehta J, Powles R, Horton C, Milan S, Singhal S, Treleaven J. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant. 1995;15:853-858.
41. Sierra J, Storer B, Hansen JA, et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood. 1997;89:4226-4235.
42. Miller RA. The aging immune system: primer and prospectus. Science. 1996;273:70-74.
43. + B cell precursors from bone marrow decreases in aging mice. Cell Immunol. 1993;147:267-278.
44. Merchant MS, Garvy BA, Riley RL. B220- bone marrow progenitor cells from New Zealand black autoimmune mice exhibit an age-associated decline in Pre-B and B-cell generation. Blood. 1995; 85:1850-1857.
45. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood. 1998;91:75-88.
46. Lipschitz DA, Udupa KB, Indelicato SR, Das M. Effect of age on second messenger generation in neutrophils. Blood. 1991;78:1347-1354.
47. Gross TG, Steinbuch M, DeFor T, et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant. 1999;23: 251-258.
48. Schultz KR, Green GJ, Wensley D, et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood. 1994;84:3212-3220.
49. Davies SM, Kollman C, Anasetti C, et al. Engraftment and survival after unrelated donor bone marrow transplantation: a report from the National Marrow Donor Program (NMDP). Blood. 2000;96:4096-4102.
50. Buckner CD, Clift RA, Sanders JE, et al. Marrow harvesting from normal donors. Blood. 1984;64: 630-634.
51. Davies SM, Shu XO, Blazar BR, et al. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood. 1995;86:1636-1642.
52. Petersdorf EW, Longton GM, Anasetti C, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood. 1995; 86:1606-1613.